🏛️ Verified NIH Record • Updated 2024-11-21
A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR) (NCT06041269)
A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: AnaptysBio, Inc.
🩺 Plain-English Summary (8th-Grade Level)
RENOIR Study: This study will evaluate the safety, tolerability, and efficacy of Rosnilimab in subjects with moderate to severe Rheumatoid Arthritis (RA)
Who can join: Review the eligibility criteria below.
Location: AnaptysBio Investigative Site 10-132 — Flagstaff, Arizona
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (92 Sites)
Showing the first 25 of 92 sites.
- AnaptysBio Investigative Site 10-132 — Flagstaff, Arizona
- AnaptysBio Investigative Site 10-130 — Glendale, Arizona
- AnaptysBio Investigative Site 10-129 — Phoenix, Arizona
- AnaptysBio Investigative Site 10-131 — Tucson, Arizona
- AnaptysBio Investigative Site 10-105 — Covina, California
- Anaptys Bio Investigative Site 10-119 — Rancho Mirage, California
- AnaptysBio Investigative Site 10-113 — San Diego, California
- AnaptysBio Investigative Site 10-127 — San Francisco, California
- AnaptysBio Investigative Site 10-136 — Temecula, California
- AnaptysBio Investigative Site 10-133 — Upland, California
- AnaptysBio Investigative Site 10-112 — Whitter, California
- AnaptysBio Investigative Site 10-103 — Aventura, Florida
- AnaptysBio Investigative Site 10-141 — Avon Park, Florida
- AnaptysBio Investigative Site 10-118 — Boynton Beach, Florida
- AnaptysBio Investigative Site 10-125 — Daytona Beach, Florida
- AnaptysBio Investigative Site 10-122 — Homestead, Florida
- Anaptys Bio Investigative Site 10-142 — Miami, Florida
- AnaptysBio Investigative Site 10-140 — Miami, Florida
- AnaptysBio Investigative Site 10-102 — Miami, Florida
- AnaptysBio Investigative Site 10-124 — Plantation, Florida
- AnaptysBio Investigative Site 10-139 — West Palm Beach, Florida
- AnaptysBio Investigative Site 10-114 — Chicago, Illinois
- AnaptysBio Investigative Site 10-145 — Monroe, Louisiana
- AnaptysBio Investigative Site 10-143 — Brookline, Massachusetts
- AnaptysBio Investigative Site 10-116 — Albuquerque, New Mexico
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Rheumatoid Arthritis
- Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/- csDMARD — Phoenix, Arizona
- A Clinical Study to Assess the Efficacy of Cannabigerol in Patients with Active Rheumatoid Arthritis. — Santa Monica, California
- Employment and Arthritis: Making it Work — Richmond, British Columbia
- Brigham and Women's Rheumatoid Arthritis Sequential Study — Boston, Massachusetts
- A Study of SPY072 in Rheumatic Disease — Avondale, Arizona
Explore by condition: All Rheumatoid Arthritis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.